Objective: To describe the spectrum of central nervous system (CNS) disease during the first year of antiretroviral therapy (ART) and to determine the contribution of neurological immune reconstitution inflammatory syndrome (IRIS).
Introduction
Neurological disorders are important causes of morbidity and mortality in HIV-infected patients [1, 2] . The use of combination antiretroviral therapy (ART) has significantly reduced the incidence and progression of HIVassociated dementia, as well as the incidence of opportunistic infections affecting the central nervous system (CNS) [3] . However, an early complication of ART is the immune reconstitution inflammatory syndrome (IRIS), which may affect the CNS [4, 5] . IRIS occurs due to an exuberant inflammatory response directed toward opportunistic pathogens [6] . This results in the paradoxical worsening of a patient's condition despite adequate antimicrobial therapy (paradoxical IRIS) or the unmasking of an occult opportunistic infection with an unusually inflammatory presentation (unmasking IRIS) [7] . Neurological IRIS is described in several HIV-related CNS disorders such as tuberculosis (TB), cryptococcal meningitis, cytomegalovirus infection and progressive multifocal leukoencephalopathy [4, 5] .
Efavirenz (EFV) may cause CNS adverse events in more than 50% of the patients [8, 9] . Furthermore, a Thai study reported an increased rate of primary CNS lymphoma and ischemic/hemorrhagic strokes in HIV-infected patients within the first 2 years of ART when compared with HIV-infected patients from the same setting in the pre-ART era [2] .
In this study, we describe the spectrum of CNS disease during the first year of ART among patients presenting to a referral hospital in South Africa.
Participants and methods
A prospective observational study at GF Jooste Hospital, a secondary-level, public sector referral hospital in Cape Town, South Africa. GF Jooste Hospital serves adults from a population of approximately 1.3 million people who reside in high-density, low-income communities. The incidence of TB in these communities exceeds 1000 cases per 100 000 of the population per annum and the antenatal HIV seroprevalence can be 30% [10] . Eleven primary-level ART clinics are situated in the referral area. Most patients attending these clinics do not have health insurance. Thus, the public sector referral hospital serves most patients with significant clinical deterioration following ART initiation.
Between 1 November 2007 and 31 October 2008 (12 months), we enrolled adult (18 years of age) HIVseropositive patients who were referred to our facility with new or recurrent neurological or psychiatric symptom(s) or sign(s) within the first year of starting ART. Patients with neurological deterioration due to peripheral neuropathy or 'delirium secondary to a general medical condition' were excluded. Doctors in the infectious diseases outpatient clinic and the admitting medical doctors were informed about the study and they screened all patients who presented to GF Jooste hospital with a medical illness. Patients who met the inclusion criteria were referred to a study physician. The study physicians also actively sort out referrals in the outpatient clinic and medical wards each day of the week (Monday-Friday). Data obtained by the study physician included demographic information, CD4 þ cell counts prior to ART initiation, ART regimen, previous/concurrent illnesses affecting the CNS, details of TB disease if present, medication use and details of neurological presentation. Thereafter, a neurological examination was performed by the study physician and investigations requested as determined by presentation. We subsequently used primary clinic and hospital medical notes, as well as the National Health Laboratories Service database to trace specimens, and the electronic hospital and primary clinic attendance registers to trace patients in order to determine the outcome 6 months after presentation. Data obtained prospectively (i.e. details regarding presentation and initial management), as well as retrospectively (i.e. outcome data), were recorded on a standardized data collection sheet. Data analysis was performed using Microsoft Excel. The incidence of referral for CNS deterioration was calculated with 95% Poisson confidence intervals (CIs) on the basis of the total number of patients initiating ART in the year preceding each study month at the 11 referring ART clinics, reduced by 10.9% to allow for losses to care. The data were obtained from monthly reports of total patients started on ART in each referring clinic and provincial cohort data on retention in care at 6 months on ART [11] . The Research Ethics Committee of the University of Cape Town approved this study.
Definitions
We defined paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) and cryptococcal meningitis immune reconstitution inflammatory syndrome (CM-IRIS) using consensus clinical case definitions [7, 12, 13] . The diagnosis of paradoxical TB-IRIS required diagnosis of active TB prior to ART initiation, response to antitubercular treatment and development of recurrent, new or worsening symptoms/signs of neurological TB within 3 months of starting ART. Paradoxical TB-IRIS was also diagnosed in patients who were diagnosed with TB after initiation of ART and subsequently developed a neurological paradoxical reaction after starting antitubercular therapy that did not have an alternative explanation. The diagnosis of paradoxical CM-IRIS required diagnosis of cryptococcal meningitis prior to ART, initial response to antifungal treatment with improvement of symptoms/signs and presentation with cryptococcal meningitis recurrence that was culture negative within 12 months of ART initiation. If there was a cryptococcal meningitis recurrence on ART and the cerebrospinal fluid (CSF) cultured Cryptococcus neoformans, the onset of the event had to be within 3 months of initiation of antifungal therapy to be defined as CM-IRIS. The diagnosis of a culture-positive cryptococcal meningitis relapse on ART required re-presentation with CSF fungal culturepositive cryptococcal meningitis and occurrence more than 3 months after start of antifungal therapy.
The diagnosis of 'delirium secondary to a general medical condition' required acute confusion secondary to sepsis owing to a nonneurological infection or metabolic abnormality (e.g. hypoxia, hypoglycemia, renal or hepatic failure).
Results
Seventy-five patients presented with neurological deterioration within 1 year of starting ART. Between Extrapulmonary disease sites include nodal (n ¼ 11), central nervous system (n ¼ 5), abdominal (n ¼ 4), pleural (n ¼ 4) and pericardial (n ¼ 2). In five patients, both pulmonary and extrapulmonary disease were present. In three patients more than one extrapulmonary site of disease was present. c For 40 patients who started antitubercular treatment prior to ART. d Deaths occurred in the following patient categories: intracerebral space occupying lesion (other than tuberculoma) (n ¼ 6), new diagnosis of neurological TB (n ¼ 2), poor adherence to antitubercular treatment (n ¼ 2), multidrug-resistant TB (n ¼ 1), new diagnosis of CM (n ¼ 3), cytomegalovirus encephalitis (n ¼ 1) and HIV encephalopathy (n ¼ 2). e Lost to follow-up occurred in the following patient categories: paradoxical TB-IRIS (n ¼ 1), multidrug-resistant TB (n ¼ 2), poor adherence to antitubercular treatment (n ¼ 1), paradoxical CM-IRIS (n ¼ 1), culture-positive CM relapse on ART (n ¼ 1), new diagnosis of CM (n ¼ 1), cerebral toxoplasmosis (n ¼ 1), intracerebral space occupying lesion of uncertain cause (n ¼ 1), EFV-induced psychosis (n ¼ 2), reactive psychosis (n ¼ 1), isolated abducens nerve palsy (n ¼ 1), varicella zoster virus radiculopathy (n ¼ 1) and bacterial meningitis (n ¼ 1).
Central nervous system tuberculosis
Twenty-seven patients (36%) presented with neurological deterioration related to TB. Paradoxical TB-IRIS was diagnosed in 16/75 patients (21%). Thirteen out of 16 of these patients received corticosteroids. At 6-months follow-up, 15/16 patients were alive and one was lost to follow-up. All patients diagnosed with tuberculoma either had a negative-serum immunoglobulin G (IgG) serological analysis for toxoplasma species or showed a good response to antitubercular treatment in the absence of treatment for toxoplasmosis.
Cryptococcal meningitis
Eighteen patients (24%) presented with deterioration related to cryptococcal meningitis. Five patients (7%) presented with paradoxical CM-IRIS, of whom one received corticosteroids. At 6-months follow-up, four of these five patients were alive and one was lost to followup.
Space occupying lesions (other than tuberculoma)
Ten patients (13%) presented with SOL due to toxoplasmosis (n ¼ 1) or of uncertain cause (n ¼ 9). The diagnosis of cerebral toxoplasmosis was on the basis of a response to antitoxoplasma treatment in the absence of antitubercular treatment. In the other nine patients, it could not be ascertained whether the SOL was related to TB or toxoplasmosis: four were already receiving antitubercular treatment and had antitoxoplasma treatment added, three were started on treatment for both TB and toxoplasmosis, one was treated only for toxoplasmosis, but died and one was only treated for TB, but died.
Psychosis
Nine patients (12%) presented with psychosis. An EFVinduced psychosis was the most likely cause in five. One patient was diagnosed with INH-induced psychosis and another was diagnosed with a reactive psychosis secondary to social stressors. A diagnosis of HIV-induced psychosis was presumed for two patients in whom no other cause could be identified.
Outcomes
At 6-months follow-up, 43 (57%) patients were alive, 17 (23%) were dead and 15 (20%) were lost to follow-up from the healthcare system (Table 1 ). The median interval from ART initiation, and presentation, to death was 67 days [interquartile range (IQR) 47-164 days] and 23 days (IQR 10-39 days), respectively.
Discussion
This is, to our knowledge, the first prospective study describing the spectrum of neurological disorders occurring within the first year of ART. TB and cryptococcal meningitis together accounted for at least 60% of cases. This is likely owing to the high incidence of TB in our setting, and profound immunosuppression at ART initiation; in 2007, 19% of adults starting ART in the Western Cape province had CD4 þ cell counts below 50 cells/ml, whereas the median CD4 þ cell counts of patients starting ART in two of the referring clinics were 131 cells/ml [14] .
Paradoxical IRIS, which was associated with TB (n ¼ 16) and cryptococcal meningitis (n ¼ 5), accounted for 28% of cases. Paradoxical CM-IRIS may occur in up to 30% of patients following ART initiation [15] [16] [17] . We previously reported neurological TB-IRIS in 12% of patients who presented with TB-IRIS [12] . The median interval from starting ART to symptom onset in our patients with 2874 AIDS 2010, Vol 24 No 18 1, 3, 4 See definitions in the text. 2 CSF culture positive for Cryptococcus neoformans at time of deterioration. 5 Space occupying lesions other than tuberculoma. 6 The most likely differential diagnoses included tuberculoma and toxoplasmosis.
TB-IRIS and CM-IRIS was 16 and 58 days, respectively. These findings are similar to previous reports [12, 15] . The management of neurological IRIS is problematic; no diagnostic test exists and treatment strategies are based on anecdotal case reports [18] . Eighty-one percent of patients with TB-IRIS and 20% of patients with CM-IRIS in our cohort received corticosteroid therapy, which may be of benefit in patients with neurological TB-IRIS [12, 18] . High mortality rates have been associated with both CM-IRIS (up to 66%) [17] and neurological TB-IRIS (at least 13%, at 6-months follow-up) [12] . No patients in our cohort who presented with IRIS died during 6-months follow-up and only one patient with TB-IRIS and one with CM-IRIS were lost to follow-up at 6 months.
New or expanding SOL developed in 21% of patients (n ¼ 16). Confirming the cause of SOL is difficult in our setting in which access to stereotactic brain biopsy is limited. Similar to previous studies [12] , we relied on available evidence to make the diagnosis. The major differential diagnoses of SOL are cerebral toxoplasmosis (diagnosed in one patient) and tuberculoma (diagnosed in six patients) [19] . In more that half of our patients (9/16), the diagnosis was uncertain. The lack of definitive diagnosis in most patients, and the associated high mortality in these patients (6/9), emphasize the challenge of managing patients with SOL.
Neurological deterioration is an important cause of clinical deterioration and death after starting ART. The referral rate of 23.3 cases per 1000 patient-years at risk is most likely an underestimate of the true incidence of neurological deterioration. Although significant neurological presentation related to a CNS cause results in referral to our facility, patients with mild symptoms or signs are not always referred; patients who are too confused or otherwise unwell to seek medical help may die at home; and patients may attend other hospitals or move out of the referral area. Furthermore, new or worsening peripheral neuropathy is a common cause for neurological deterioration after starting ART [20] . However, as most peripheral neuropathies are managed at primary care level, we did not include these patients in our study. In this study, the challenges posed by the management of patients with neurological deterioration are reflected in poor outcome (23% died), and high rate of loss to follow-up (20%), at 6 months. In comparison, among all patients starting ART in our setting, mortality and loss to follow-up is considerably lower. The cumulative mortality rate during the first year of ART (from 2004 to 2007 in the largest ART clinics in our referral area) was 8%, and 3-5% of patients were lost to follow-up during the first year of ART [21] . In a busy ART program, clinic attendance and adherence to ART require patient mobility, insight and motivation. Neurological deterioration makes this difficult, especially if there is inadequate treatment support from family or friends. Patients with psychosis or confusion may not have the insight to seek medical help and may default ART and other medical therapies. Furthermore, patients with weakness or other neurological impairment may be physically incapable of seeking medical care independently. This may contribute to the high loss to follow-up rate we observed.
Conclusion
In our setting, opportunistic infections, notably TB and cryptococcosis, were the most important causes for neurological deterioration during the first year of ART. Over a quarter of patients were related to paradoxical IRIS. Our study has particular relevance to ART programs in high TB prevalence regions. We highlight the challenges associated with the management of these in patients in resource-constrained settings.
